ProfileGDS4718 / 203956_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 85% 84% 92% 84% 83% 94% 94% 84% 87% 84% 84% 84% 93% 93% 93% 86% 87% 93% 91% 95% 84% 83% 86% 84% 85% 93% 84% 98% 86% 96% 91% 95% 84% 84% 92% 92% 93% 84% 82% 88% 87% 92% 92% 95% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]8.5059385
GSM549102patient 115, normal, homogenized [OPG study]8.2853484
GSM549104patient 119, normal, homogenized [OPG study]9.6206192
GSM549108patient 138, normal, homogenized [OPG study]8.2363784
GSM549119patient 077, normal, homogenized [OPG study]8.1685683
GSM549133patient 032, cancer, homogenized [OPG study]10.065794
GSM549139patient 042, cancer, homogenized [OPG study]10.034694
GSM549099patient 107, normal, homogenized [OPG study]8.3072384
GSM549109patient 139, normal, homogenized [OPG study]8.7829987
GSM549110patient 046, normal, homogenized [OPG study]8.2980784
GSM549114patient 063, normal, homogenized [OPG study]8.3918984
GSM549122patient 082, normal, homogenized [OPG study]8.3976884
GSM549134patient 033, cancer, homogenized [OPG study]9.663693
GSM549136patient 036, cancer, homogenized [OPG study]9.7006793
GSM549140patient 044, cancer, homogenized [OPG study]9.8100693
GSM549111patient 047, normal, homogenized [OPG study]8.7448786
GSM549113patient 057, normal, homogenized [OPG study]8.8653987
GSM549132patient 031, cancer, homogenized [OPG study]9.6084593
GSM549137patient 038, cancer, homogenized [OPG study]9.3052691
GSM549142patient 047, cancer, homogenized [OPG study]9.717595
GSM549100patient 110, normal, homogenized [OPG study]8.299284
GSM549107patient 135, normal, homogenized [OPG study]8.1839883
GSM549115patient 068, normal, homogenized [OPG study]8.7080186
GSM549116patient 072, normal, homogenized [OPG study]8.4266684
GSM549120patient 078, normal, homogenized [OPG study]8.504285
GSM549131patient 030, cancer, homogenized [OPG study]9.7709193
GSM549118patient 074, normal, homogenized [OPG study]8.4011384
GSM549129patient 027, cancer, homogenized [OPG study]10.846798
GSM549123patient 088, normal, homogenized [OPG study]8.578686
GSM549124patient 006, cancer, homogenized [OPG study]10.407796
GSM549126patient 015, cancer, homogenized [OPG study]9.2980591
GSM549128patient 025, cancer, homogenized [OPG study]10.205395
GSM549103patient 117, normal, homogenized [OPG study]8.1338984
GSM549117patient 073, normal, homogenized [OPG study]8.4102884
GSM549138patient 041, cancer, homogenized [OPG study]9.6423392
GSM549141patient 045, cancer, homogenized [OPG study]9.6962292
GSM549130patient 028, cancer, homogenized [OPG study]9.7012693
GSM549101patient 111, normal, homogenized [OPG study]8.331784
GSM549105patient 128, normal, homogenized [OPG study]8.0396982
GSM549106patient 134, normal, homogenized [OPG study]9.0771688
GSM549112patient 048, normal, homogenized [OPG study]8.7167487
GSM549125patient 011, cancer, homogenized [OPG study]9.4277192
GSM549127patient 024, cancer, homogenized [OPG study]9.438492
GSM549135patient 035, cancer, homogenized [OPG study]10.366695